Inducers |
Erastin |
System xc- |
prevents cystine import, causes GSH depletion |
[1] |
|
IKE |
System xc- |
prevents cystine import, causes GSH depletion |
[97] |
|
Glutamate |
System xc- |
high extracellular glutamate leads to prevent cystine import, causes GSH depletion |
[98] |
|
IFNG/IFNγ |
System xc- |
Down-regulates the expression of SLC3A2 and SLC7A11, two subunits of system xc- |
[76] |
|
Sorafenib |
System xc- |
Inhibits system xc- in a non-enzymatic target-dependent manner |
[99] |
|
Sulfasalazine |
System xc- |
Inhibition of nuclear factor κB signaling pathway; inhibition of xc-transporter |
[99] |
|
FIN56 |
GPX4 |
Cause GPX4 depletion |
[100] |
|
FINO2 |
GPX4 |
Inactive GPX4 and oxidizes iron |
[101] |
|
Altretamine |
GPX4 |
Inhibits GPX4 activity, causes ROS accumulation |
[102] |
|
JKE-1674/1716 |
GPX4 |
Inhibits GPX4 activity, causes ROS accumulation |
[103] |
|
ML162 |
GPX4 |
Inhibits GPX4 activity, causes ROS accumulation |
[28] |
|
ML210 |
GPX4 |
Inhibits GPX4 activity, causes ROS accumulation |
[104] |
|
RSL3 |
GPX4 |
Inhibits GPX4 activity, causes ROS accumulation |
[28] |
|
Artemisinin |
Organic peroxides |
ROS manufacturing, disruption of antioxidant defenses by downregulates of GPX4 and GSH causes an imbalance in intracellular oxidative responses |
[105] |
|
Artesunate |
Organic peroxides |
Causes rapid ROS accumulation |
[106] |
|
Salinomycin |
Ferritinophagy |
Increases intracellular iron, causes peroxidation by activating ferritinophagy |
[107] |
|
Ironomycin |
Ferritinophagy |
Increases intracellular iron, causes peroxidation by activating ferritinophagy |
[108] |
|
iFSP1 |
FSP1 |
Inhibit FSP1 activity, cause the accumulation of lipid peroxidation |
[109] |
|
BSO |
GCLC |
Induces GSH depletion |
[110] |
|
Doxorubicin |
HO-1 |
Induces iron overload |
[111] |
Inhibitors |
CoQ10 |
Antioxidant/RTA |
Prevents lipid peroxidation by the FSP1-catalyzed ubiquinol form |
[100] |
|
Fer-1 |
Antioxidant/RTA |
Prevents the accumulation of ROS by reducing activity |
[1] |
|
Lip-1 |
Antioxidant/RTA |
Inhibits lipid peroxidation directly |
[112] |
|
Vitamin E |
Antioxidant/RTA |
Inhibits lipid peroxidation directly |
[113] |
|
NAC |
Antioxidant/RTA |
Suppresses ferroptosis through supplementing GSH |
[28] |
|
Ciclopirox |
Iron chelator |
Reduces intracellular free iron |
[1] |
|
Deferiprone |
Iron chelator |
Reduces intracellular free iron |
[114] |
|
Deferoxamine |
Iron chelator |
Reduces intracellular free iron |
[1] |
|
Dexrazoxane |
Iron chelator |
Reduces intracellular free iron |
[115] |
|
Baicalein |
ALOXs |
Reduces ROS by inhibits ALOXs, and stabilizes GPX4 to protect cells from excessive lipid peroxidation |
[116] |
|
AA-861 |
ALOXs |
Inhibits lipid ALOXs-mediated peroxidation |
[117] |
|
CDC |
ALOXs |
Inhibits lipid ALOXs-mediated peroxidation |
[117] |
|
Triacsin C |
ACSL4 |
Prevents the transfer process of PUFA to the cell membrane, inhibits lipid ACSL4-mediated peroxidation |
[118] |
|
Troglitazone |
ACSL4 |
Prevents the transfer process of PUFA to the cell membrane, inhibits lipid ACSL4-mediated peroxidation |
[119] |
|
Rosiglitazone |
ACSL4 |
Prevents the transfer process of PUFA to the cell membrane, inhibits lipid ACSL4-mediated peroxidation |
[118] |
|
DPI |
NOXs |
Inhibit lipid NOXs-mediated peroxidation |
[120] |
|
TMZ |
System xc- |
Induces system xc-expression |
[121] |
|
KI-696 |
Keap1 |
Binds to Keap1 and prevents it from mediating NRF2 degradation |
[122] |
|
Lactate |
HCAR1/MCT1 |
Promotes PUFAs production |
[123] |
|
MUFAs |
Lipid |
Block PUFA peroxidation |
[124] |